Ann: Clinical Study Result , page-7

Benson, that is the $11 question - over 12000 on offer at $11 this morning :-)

Seriously, your Q is one we are all trying to work out.

Various figures have been bandied around, but somewhere around the 100k+ would be reachable - however that may take several years (5 or more) to get there.

Risk - some other magic drug comes along that gives a better result than SRX, and blows them out of the water.

My view, and it is only my view is that 30,000 doses in 2015/16 is on the cards.

This would suggest a net present value far in excess of $11, but something s only worth what another will pay for it!

You will note the volumes are getting much larger, and I would expect some more analysts to start covering SRX.

Buyer beware.